A detailed history of Baldwin Brothers LLC transactions in Embecta Corp. stock. As of the latest transaction made, Baldwin Brothers LLC holds 2 shares of EMBC stock, worth $40. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$40
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$12.87 - $19.09 $386 - $572
-30 Reduced 93.75%
2 $0
Q4 2022

Jan 27, 2023

SELL
$25.29 - $35.48 $556 - $780
-22 Reduced 40.74%
32 $0
Q3 2022

Oct 14, 2022

SELL
$24.0 - $33.42 $312 - $434
-13 Reduced 19.4%
54 $2,000
Q2 2022

Jul 18, 2022

BUY
$24.78 - $33.36 $1,660 - $2,235
67 New
67 $2,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.